Stevanato Group S.p.A. (STVN) Reports Q1 EPS of EUR0.11

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. ANT
3. SPY
4. META
5. FFAI
6. FFR
7. CART
8. LLY
9. TSLA
10. FICO

Go back to Stevanato Group S.p.A. (STVN) Reports Q1 EPS of EUR0.11

Stevanato Group Reports First Quarter 2022 Financial Results

May 10, 2022 6:30 AM EDT

- The Company is Maintaining its Fiscal 2022 Guidance -

PIOMBINO DESE, Italy--(BUSINESS WIRE)-- Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the first quarter of 2022.

First Quarter 2022 Highlights (compared to the same period last year)

First quarter revenue increased 10% to 212.1 million, diluted earnings per share were 0.10 and adjusted diluted earnings per share were 0.11, Adjusted EBITDA totaled 54.0 million with an adjusted... More